Prominence, yes. But are they generally better than non-deep learning models? My understanding was that this is not the case, but I don't follow this field closely.
14,964 karma · joined September 7, 2009
Previously founded MyChances.net (acquired by Parchment in 2011).
Email: james@{my HN username}.com
https://carbocation.com
topcolor #f6f6ef
Prominence, yes. But are they generally better than non-deep learning models? My understanding was that this is not the case, but I don't follow this field closely.
These models are only looking at the images. They are inferring demographics.
There are plenty of tools that have been developed to enforce that models perform in a manner that is unbiased across some dimension (e.g., sex, or hospital, etc). (For example unsupervised domain adaptation.) I think that splitting the field with jargon makes it more difficult to follow the breadth of the field.
They call demographics like age and sex "shortcuts" but I find this to be a frustrating term since it seems to obscure what's happening under the hood. (They cite many papers using the same word, so I'm not blaming them for this usage.) Men are typically larger; old bones do not look like young bones. There is plenty of biology involved in what they refer to as demographic shortcuts.
I think you could take the same results and say "Models are able to distinguish men from women. For our purposes, it's important that they cannot do this. Therefore, we did XYZ on these weakly labeled public databases." But perhaps that sounds less exciting.
It's incredibly difficult to imagine doing a good job of regulating model training, especially in a few years when the available flops are high enough that this limit is being hit often.
It's much more straightforward to regulate actions: constructing WMD is illegal, synthesizing drugs is illegal, etc.
If the state wants to tighten up its laws about various activities, go for it. That's the right place to act. Injecting itself into the model training process seems very unlikely to yield any substantive benefits and very likely to hinder progress.
> Selatogrel is a P2Y12 receptor antagonist
So this is basically like chewing on ticag, but faster.[1]
1 = https://jamanetwork.com/journals/jamacardiology/fullarticle/...